| Predicted Trait | |
| Reported Trait | Systolic blood pressure | 
| Mapped Trait(s) | systolic blood pressure (EFO_0006335) | 
| Score Construction | |
| PGS Name | SBP_MVP | 
| Development Method | |
| Name | PRSice-2 | 
| Parameters | R2 = 0.1, 0.2 and 0.3, CV-PRS | 
| Variants | |
| Original Genome Build | GRCh38 | 
| Number of Variants | 24,807 | 
| Effect Weight Type | beta | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000531 | 
| Citation (link to publication) | Kurniansyah N et al. Nat Commun (2022) | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | 
|---|---|---|---|
| GWAS Catalog: GCST007270 Europe PMC: 30578418 | 225,112 individuals | European | MVP | 
| GWAS Catalog: GCST007270 Europe PMC: 30578418 | 63,490 individuals | African unspecified | MVP | 
| GWAS Catalog: GCST007270 Europe PMC: 30578418 | 22,802 individuals | Hispanic or Latin American | MVP | 
| GWAS Catalog: GCST007270 Europe PMC: 30578418 | 4,792 individuals | Asian unspecified | MVP | 
| GWAS Catalog: GCST007270 Europe PMC: 30578418 | 2,695 individuals | Native American | MVP | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| — | 2,803 individuals, 33.5 % Male samples | African American or Afro-Caribbean | BioMe | — | Mean = 55.9 years Sd = 12.5 years | — | — | — | 
| — | 151 individuals, 44.4 % Male samples | Asian unspecified | BioMe | — | Mean = 53.14 years Sd = 13.52 years | — | — | — | 
| — | 2,506 individuals, 52.2 % Male samples | European | BioMe | — | Mean = 60.42 years Sd = 13.96 years | — | — | — | 
| — | 4,187 individuals, 37.5 % Male samples | Hispanic or Latin American | BioMe | — | Mean = 57.72 years Sd = 13.18 years | — | — | — | 
| — | 667 individuals, 57.9 % Male samples | Not reported | BioMe | — | Mean = 57.51 years Sd = 13.1 years | — | — | — | 
| PGS Performance Metric ID (PPM) | PGS Sample Set ID (PSS) | Performance Source | Trait | PGS Effect Sizes (per SD change) | Classification Metrics | Other Metrics | Covariates Included in the Model | PGS Performance: Other Relevant Information | 
|---|---|---|---|---|---|---|---|---|
| PPM020254 | PSS011312| Multi-ancestry (including European)| 39,035 individuals | PGP000531 | Kurniansyah N et al. Nat Commun (2022) | Reported Trait: Prevelant hypertension | — | AUROC: 0.757 [0.744, 0.771] | — | sex, age, age2, study site, race/ethnic background, smoking status, BMI, and 11 ancestral principal components | — | 
| PGS Sample Set ID (PSS) | Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS011312 | — | — | 8,822 individuals, 31.9 % Male samples | — | African American or Afro-Caribbean | — | 6 cohorts 
 | — | 
| PSS011312 | — | — | 6,718 individuals, 38.0 % Male samples | — | Hispanic or Latin American | — | 6 cohorts 
 | — | 
| PSS011312 | — | — | 794 individuals, 37.9 % Male samples | — | Asian unspecified | — | MESA, WHI | — | 
| PSS011312 | — | — | 22,701 individuals, 27.8 % Male samples | — | European | — | ARIC, CHS, FHS, MESA, WHI | — |